Revenues reached EUR 1,819.0 million (2006: EUR 1,801.3 million). Earnings before interest and tax (EBIT) rose to EUR 151.9 million (2006: EUR 148.2 million). However, due to planned non-recurring expenses totaling EUR 27.6 million, EBIT (after non-recurring expenses) was reduced to EUR 124.3 million. For the current fiscal year, the Company anticipates a slight increase in revenues and stable EBIT, which will again be impacted by non-recurring expenses of between EUR 20 million and EUR 25 million, in particular for organizational measures (IT) and to speed up development work.

The increase in revenues is wholly due to the Dräger Safety division’s exceptional growth spurt, which led to an 8.2 percent increase in revenues, taking them to EUR 637.5 million. The Medical division, on the other hand, recorded a year-on-year drop in revenues of almost 2.4 percent to EUR 1,209.4 million. Order intake growth at Dräger Safety outdid revenue growth, climbing 20.3 percent compared with the prior year. Large project orders in particular are an excellent foundation for revenues in 2008 and 2009. Order intake at Dräger Medical was 4.0 percent below the prior-year figure.

The Dräger Group’s assets, equity and liabilities remained stable in the past fiscal year, which is reflected in the balance sheet total of EUR 1,637.5 million (2006: EUR 1,636.3 million).

Source: German Healthcare Export Group e.V.